sults and again demonstrates a fundamental difference between in vitro and in vivo systems. In addition to these metabolic relationships, we were able to demonstrate that the in vitro primaquine effect is probably due to a structural change in the erythrocyte membrane.
Methods
Blood from normal adult males was collected in heparin. Erythrocytes were separated from plasma by centrifugation and washed three times in 0.9% sodium chloride (referred to as saline). G-6-PD was determined by measuring the reduction of TPN to TPNH in a Beckman DB spectrophotometer at 340 m,. 1 The values obtained for normal individuals whose red cells were used in this study were 1.693 ± 0.313 (SD) U 2 per ml of red cells. Erythrocytes from the five Negro male G-6-PD deficient individuals had enzyme activities of 0.166 ± 0.032 U per ml of red cells. All experiments used normal red cells unless otherwise indicated.
Incubations were in siliconized 25-ml Erlenmeyer flasks in air in a shaking water bath at 370 C. One ml of washed red blood cells was added to 2 ml of a saline solution containing the appropriate constituents. For experiments in which red cells were depleted of substrate, the cells were prepared by preincubation at 37°C for 2 hours before the addition of the hemolytic drug. All incubations were for 2 hours unless otherwise stated.
Primaquine diphosphate, pamaquine citrate, isopentaquine oxalate,3 hydroquinone, and menadione sodium bisulfite were dissolved in saline before incubation, and the pH was adjusted to 7.4 with sodium hydroxide. Crystalline acetylphenylhydrazine and #-naphthol were added directly to the incubation mixture. Neither of these drugs altered the pH of the red cell suspension. The pH of the reaction mixture remained constant during incubation unless glucose or other metabolized hexoses were added. Then a small decrease of pH (less than 0.2 U) occurred. This was shown to have only a slight effect on osmotic fragility by preliminary experiments in which the pH of the incubation mixture was decreased 0.2 U with HC1 before incubation. Increase in hemolysis was less than 5.4% in 0.85% NaCl in four experiments.
Hemoglobin determinations by the cyanmethemoglobin method of Crosby, Munn, and Furth (12) were carried out on the whole blood sample and the supernatant medium after incubation. Hematocrits were determined by the microhematocrit method. Per cent hemolysis was calculated as: % hemolysis = [ODsupernatant (1-Hct)/ ODwhole sample X dilution factor] X 100.
The dilution factor varied from 1 to 10, depending upon the amount of supernatant material used in the hemoglobin determination. Potassium concentrations were determined by flame photometry with an internal lithium standard. The loss of potassium from the red cells to the supernatant fluid was calculated as: % potassium loss = [K, (1-Hct)/KRBc X 0.33] X 100. K. is the potassium concentration of the supernatant fluid after incubation, and Hct refers to the microhematocrit of the red cell suspension after incubation. KRBC is the potassium concentration of the washed, packed red cells before incubation, and 0.33 refers to the initial concentration of these packed cells in the incubation system. No correction for trapped fluid, which was potassium free, was necessary in calculating KRBC, since the total volume of packed cells added to the suspension was the volume in which KRBC was contained. It should be recognized that this equation oversimplifies the expression of the loss of the red cell's ability to actively maintain its potassium concentration. This was apparent in other experiments in our primaquine incubation system when equilibrium between intracellular and extracellular potassium was attained, and yet a significant proportion of the potassium remained within the still'intact cells.
Osmotic fragility was determined after incubation by transferring 0.02 ml of the incubation mixture into 5 ml of buffered sodium chloride solutions of varying concentrations and distilled water as described by Parpart and as- 
Results
Effect of substrate on potassium loss, hemolysis, and osmotic fragility. Increasing concentrations of primaquine caused the loss of red cell potassium before the onset of hemolysis. At sublytic concentrations, primaquine produced a pattern of red cell osmotic fragility characterized by a small population of osmotically fragile cells. The primaquine concentration required for these changes was similar to that previously reported (6, 14) . The pentose moiety of purine nucleosides is rility was studied after incubation with and split off and phosphorylated at the red cell memhiout glucose for varying times. Primaquine brane and subsequently metabolized (19) . ie caused a small decrease in osmotic resistance Adenosine and guanosine increased primaquinegure 2). Table II ure 4). Adenine (2 mM) and 2 and 20 mM ATP had no effect. Deoxyribose from deoxyadenosine is phosphorylated as well as ribose by red cell membrane nucleoside phosphorylase but subse- When added to primaquine incubation systems, deoxyadenosine consistently had an intermediate effect in stimulating osmotic fragility. The ability of glucose, galactose, and adenosine to support primaquine-induced osmotic fragility was related to substrate concentration ( Figure 5 ). The minimal effective concentration of both glucose and adenosine was 5 X 10-4 mole per L. As described above, galactose was as effective as glucose in 10-2 M concentrations. However, at concentrations of less than 1C-2 mole per L, galactose was much less effective than glucose.
A further indication of the metabolic nature of the glucose effect was its temperature dependence. Figure 6 represents the increase in primaquineinduced osmotic fragility caused by the presence of glucose at 370, 26°, and 40 C. Diminishing incubation temperature to 26°almost abolished the glucose effect. At 40 glucose was only minimally effective in stimulating primaquine action. The relation of incubation temperature to osmotic fragility itself was less simple. Primaquine was less effective at 260, but at 40 it produced even greater osmotic fragility than at 37°. This phenomenon is currently being studied.
Effect of products of metabolism. The end product of red cell glucose metabolism, lactate itself, could be the stimulatory factor of primaquine action, or an intermediary metabolite accumulated behind a metabolic block may be responsible. Oxidative hemolytic compounds have been shown to decrease lactate production, suggesting a metabolic block (21) . For example, acetylphenylhydrazine oxidizes DPNH in vitro and causes the accumulation of pyruvic acid in hemolysates (22) . Neither sodium lactate nor sodium pyruvate had any effect on the osmotic fragility of red cells incubated with primaquine (Table III) .
G-6-PD deficient red cells. G-6-PD deficient red cells demonstrate the same in vitro potassium loss and hemolysis as normal cells when incubated with primaquine (23) . Primaquine also induces the same degree of osmotic fragility in normal and G-6-PD deficient red cells. The presence of glucose caused an increase in primaquine-induced osmotic fragility of the G-6-PD deficient cells, but the increase was significantly less than that caused in normal cells (Figure 7) . Purine nucleosides were also less effective in stimulating primaquine action on G-6-PD deficient red cells than in normal cells.
Other hemolytic agents. Two other 8-aminoquinoline antimalarial drugs, pamaquine and isopentaquine, were studied. In 2 mM concentrations both produced a pattern of erythrocyte osmotic fragility similar to that produced by primaquine. The addition of 10 mM glucose to these systems also caused a marked increase in the osmotic fragility of the red cells. Acetylphenylhydrazine, /3-naphthol, hydroquinone, and menadione sodium bisulfite were also found to increase the osmotic fragility of erythrocytes. With the exception of 
FIG. 7. THE EFFECT OF GLUCOSE ON OSMOTIC FRAGILITY PRODUCED BY PRIMAQUINE IN NORMAL AND G-6-PD DE-FICIENT RED CELLS. Both normal and glucose 6-phosphate dehydrogenase (G-6-PD) deficient red cells (RBC)
were incubated for 2 hours without primaquine (control) and with 2 mM primaquine with or without added 10 mM glucose. The figures represent the mean values of five G-6-PD deficient and eight normal subjects. Control curves for normal and G-6-PD deficient cells were the same., /3-naphthol, far greater concentrations of these agents had to be used to attain an increase in osmotic fragility similar to that caused by 2 mM primaquine in 2 hours. This agrees with Harley and Mauer (24), who found that /8-naphthol and primaquine caused increased osmotic fragility out of proportion to other oxidative damage when compared with acetylphenylhydrazine. They also reported that f8-naphthol-and primaquine-induced osmotic fragility was enhanced by glucose. In the present study only the primaquine effect was stimulated by glucose. The addition of glucose had no effect on the action of acetylphenylhydrazine. With f8-naphthol, hydroquinone, and menadione sodium bisulfite hemolysis was visibly less, and osmotic fragility decreased in the presence of glucose (Figure 8 ). Depletion of substrate before the addition of the hemolytic agent slightly enhanced the osmotic fragility caused by all four of these other oxidative agents. Therefore, in con- trast to primaquine, metabolic activity acted to protect the red cell against the action of these drugs.
Primaquine uptake and binding by red cells. Primaquine uptake by red cells was studied to de- termine whether or not substrate served as a source of energy for primaquine transport or binding to its site of action. Primaquine was taken up by red cells in less time than it takes to mix and centrifuge the sample. During 2 hours of incubation at 370 there was no further cellular accumulation of primaquine. Red cell uptake of primaquine was independent of substrate concentration (Table IV) .
After primaquine uptake had been determined, the red blood cells were washed once in 20 vol of saline, which removed more than 90%o of the primaquine. This occurred regardless of the presence or depletion of substrate. The concentration of primaquine remaining in the cells after washing one to six times was the same but below the level of accuracy of this method. Therefore, whether a smaller but significant amount of primaquine is irreversibly bound to the red cells was not determined.
Discussion
Substrate stimulation of primaquine hemolysis provides further evidence of damage to the erythrocyte membrane, but of a type different from that responsible for prelytic potassium loss. The addition of glucose had no effect on potassium loss but caused a significant increase in hemolysis. Therefore, membrane damage indicated by cation permeability was unchanged, but the ability of the red cell to resist subsequent lysis was diminished. This was more clearly revealed by studies of osmotic fragility. Osmotic hemolysis is the result of progressive swelling of the red cell until lysis occurs at the critical hemolytic volume. Increased osmotic fragility may occur by two processes: the red cell may become more permeable to cations and therefore reach its critical hemolytic volume sooner, or the critical volume itself may be decreased allowing less swelling before hemolysis (25) . Increased cation permeability as a cause for the enhancement of primaquine-induced osmotic fragility by glucose seemed unlikely, since there was no increase of potassium loss during incubation in the presence of glucose. The alternative explanation of diminished critical volume was confirmed by demonstrating spherocytosis without a cell volume change caused by primaquine with glucose. Primaquine alone produced no spherocytosis under these conditions, Such a shape change of the red cell without an accompanying volume change indicates direct membrane damage by a diminished surface area and therefore a decreased critical hemolytic volume.
Explanations other than a metabolic effect were at first considered for the mechanism of glucose stimulation of primaquine action. Initially, it was considered that glucose may act only to increase the intracellular osmotic pressure after being actively transported into the cell. This was dismissed by the demonstration that only actively metabolized compounds supported increased primaquine hemolysis. Actively transported but nonmetabolized substances had no effect. Another early consideration was that the monosaccharide transport system itself may be involved in the stimulation of primaquine hemolysis. Erythrocyte membrane sulfhydryl groups, which are essential for glucose transport (26) , have been suggested as possibly being important in the mechanisms of oxidative hemolysis (14, 27) . It was thought that involvement of these sulfhydryl groups in transport processes might diminish the ability of the red cell to protect itself against damage. However, this possibility also was ruled out by the ineffectiveness of similarly transported but nonmetabolized sugars. Conclusive evidence that the osmotic fragility caused by primaquine was substrate dependent came with the demonstration of protection by inhibition of metabolism. The addition of 2-deoxyglucose, a competitive inhibitor of glucose metabolism (18) , partially protected the red cells from primaquine action. Depletion of endogenous substrates by incubation of the red cells at 370 C before adding primaquine afforded almost complete protection against the development of osmotic fragility.
Of the various sugars tested, glucose, fructose, mannose, and galactose were all effective in supporting primaquine-induced osmotic fragility. Primaquine action was supported by purine nucleosides as well as metabolized hexoses. The nucleoside effect was localized to the ribose moiety by the finding that adenine alone was ineffective. Also the concentration requirement for adenosine was identical to that of glucose.
A direct relation between metabolism as determined by lactate production and stimulation of primaquine action was obtained using purine nucleosides as substrates. Adenosine and guanosine were equal to glucose in supporting primaquine action; deoxyadenosine had only an intermediate effect. Lowy and associates (20) have shown that the same amount of pentose is metabolized (i.e., diminished measurable pentose concentration) by red cells from both adenosine and deoxyadenosine. However, they also showed that lactate production from deoxyadenosine is only onehalf that produced by adenosine. Although lactate is specifically the end product of glycolysis, diminished lactate production by deoxyribose could result from a metabolic deficiency at any point after phosphorylation at the membrane by nucleoside phosphorylase. Therefore, the deoxyadenosinesupported increase in osmotic fragility with primaquine quantitatively correlated with deoxyribose metabolism.
Once a substrate requirement for primaquineinduced membrane damage was established, the character of the reaction had to be determined. Possible energy-requiring steps in primaquine hemolysis are 1) active transport of the drug into and binding by the erythrocytes and 2) metabolic transformation of primaquine to an active compound.
The first possibility was eliminated by determining the uptake and binding of primaquine to red cells under various conditions of incubation. In these experiments, two-thirds of the primaquine was bound to red cells immediately, and no more was taken up during incubation (Table IV) . Es (38) which stated that there is significant 14CO2 produced that is stimulated by methylene blue, indicating activity of the pentose shunt. The 14CO2 produced was less than that produced with glucose as a substrate, which is consistent with the quantitative difference in the ability to support primaquine action demonstrated in Figure 5 . Ribose phosphate from adenosine and guanosine also may not be metabolized through the pentose phosphate pathway as much as glucose. Some of the metabolic intermediates from ribose phosphate are recycled through the pentose shunt in the presence of oxidative drugs (21) , but others will proceed directly to the formation of lactate. This may be why adenosine is slightly less effective than glucose in stimulating primaquine hemolysis ( Figure 5 ). Primaquine oxidation is also suggested by the fact that other 8-aminoquinoline drugs, pamaquine and isopentaquine, similarly required substrate for the production of in vitro erythrocyte osmotic fragility. Other oxidative hemolytic drugs tested, acetylphenylhydrazine, hydroquinone, /8-naphthol, and menadione sodium bisulfite, showed no enhancement of their in vitro effect with the addition of glucose. In fact, the depletion of endogenotis substrates increased the effect of these drugs.
The paradox of these experiments is that "primaquine sensitive" erythrocytes were actually more resistant than normal red cells to the in vitro action of primaquine in the presence of substrate. However, this in vitro phenomenon must be of little significance in vivo. If TPNH dependent biodegradation is required for primaquine to become active, other cells of the body would completely take over this function.
The discrepancy between concentrations of primaquine required for in vitro hemolysis and the dose that can precipitate hemolytic anemia in sensitive individuals is still unexplained. Perhaps an active metabolite of primaquine has a greater effect on sensitive red cells in vivo in producing membrane damage with diminished surface area, spherocytosis, and subsequent lysis or sequestration. Summary Substrate greatly, enhanced the effect of primaquine on normal red cells in vitro. The presence of substrate produced no change in prelytic potassium loss, a significant but small increase in hemolysis, and a great increase in osmotic fragility. Depletion of endogenous red cell substrates before the addition of primaquine prevented the development of primaquine-induced osmotic fragility.
Red cells incubated with subhemolytic concentrations of primaquine in the presence of substrate became spherocytes without an increase in volume, indicating that there was an effect on the red cell membrane that diminished surface area and decreased critical hemolytic volume.
Glucose 6-phosphate dehydrogenase (G-6-PD) deficient erythrocytes were less susceptible than normal red cells to primaquine-induced osmotic fragility in the presence of substrate. Therefore, the site of the metabolic reaction supporting primaquine action is probably in the pentose phosphate pathway. This pathway may provide electron donors so that primaquine can be metabolized to a more active compound. The reactions involved in the structural transformation of quinoline drugs have been shown in other systems to require TPNH and oxygen. Since G-6-PD deficient red cells are less able to produce TPNH, this may explain their paradoxical resistance to primaquine action in vitro.
